Exelixis
EXEL
#1695
Rank
NZ$16.95 B
Marketcap
$59.36
Share price
0.52%
Change (1 day)
71.31%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company